Background: L-DOPA is an amino acid precursor to the neurotransmitter dopamine that is extensively used as a prodrug for the treatment of Parkinson’s disease. However, L-DOPA is an unstable compound: when exposed to light or added to aqueous solutions, it may degrade, compromising its therapeutic properties. Methods: In this work, a new type of drug-loaded cyclodextrin-based nanosponge, obtained using molecular imprinting, is described for the prolonged and controlled release of L-DOPA. The molecularly imprinted nanosponges (MIP-NSs) were synthesized by cross-linking β-cyclodextrin with 1,1ʹ-carbonyldiimidazole in DMF in the presence of L-DOPA as a template molecule. TGA, DSC and FTIR analyses were performed to characterize the interactions between L-DOPA and the two nanosponge structures. Quantitative NMR spectroscopy was used to determine the amount and the affinity of L-DOPA entrapped in the nanosponges. The in vitro L-DOPA release kinetics from the NSs were quantitatively determined by HPLC analysis. Results: The MIP-NSs show a slower and more prolonged release profile than the non-imprinted nanosponges. No degradation of the L-DOPA hosted in the MIP-NSs was observed after long-term storage at room temperature. Conclusions: The MIP-NSs are a promising alternative for the storage and controlled delivery of L-DOPA.

Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of L-DOPA: perspectives for the treatment of Parkinson’s disease

TROTTA, Francesco;CALDERA, FABRIZIO;CAVALLI, Roberta;SOSTER, MARCO;RIEDO, CHIARA;BIASIZZO, MIRIAM;BRUNELLA, VALENTINA GIOVANNA
2016

Abstract

Background: L-DOPA is an amino acid precursor to the neurotransmitter dopamine that is extensively used as a prodrug for the treatment of Parkinson’s disease. However, L-DOPA is an unstable compound: when exposed to light or added to aqueous solutions, it may degrade, compromising its therapeutic properties. Methods: In this work, a new type of drug-loaded cyclodextrin-based nanosponge, obtained using molecular imprinting, is described for the prolonged and controlled release of L-DOPA. The molecularly imprinted nanosponges (MIP-NSs) were synthesized by cross-linking β-cyclodextrin with 1,1ʹ-carbonyldiimidazole in DMF in the presence of L-DOPA as a template molecule. TGA, DSC and FTIR analyses were performed to characterize the interactions between L-DOPA and the two nanosponge structures. Quantitative NMR spectroscopy was used to determine the amount and the affinity of L-DOPA entrapped in the nanosponges. The in vitro L-DOPA release kinetics from the NSs were quantitatively determined by HPLC analysis. Results: The MIP-NSs show a slower and more prolonged release profile than the non-imprinted nanosponges. No degradation of the L-DOPA hosted in the MIP-NSs was observed after long-term storage at room temperature. Conclusions: The MIP-NSs are a promising alternative for the storage and controlled delivery of L-DOPA.
EXPERT OPINION ON DRUG DELIVERY
13
12
1671
1680
Cyclodextrins; in vitro release studies; inclusion compounds; L-DOPA; molecularly Imprinted Polymers; Nanosponges; 3003
Trotta, Francesco; Caldera, Fabrizio; Cavalli, Roberta; Soster, Marco; Riedo, Chiara; Biasizzo, Miriam; Uccello Barretta, Gloria; Balzano, Federica; Brunella, Valentina
File in questo prodotto:
File Dimensione Formato  
L-DOPA-paper_4aperto.pdf

accesso aperto

Descrizione: POSTPRINT_PAPER
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 1.72 MB
Formato Adobe PDF
1.72 MB Adobe PDF Visualizza/Apri
PAPER.pdf

non disponibili

Descrizione: PDF EDITORIALE
Tipo di file: PDF EDITORIALE
Dimensione 1.83 MB
Formato Adobe PDF
1.83 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1622949
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 50
social impact